Please assess the completion status of the following clinical trial:

Trial Title: Open-label MNS for Tourette Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Completed participation in the study called Peripheral induction of inhibitory brain circuits to treat Tourette's: pilot~* Informed consent by adult participant, or assent by child and informed consent by guardian~Exclusion Criteria:~* Has an implanted device that could be affected by electrical current~* Pregnancy known to participant or (for children) to the parent~* Severe or unstable systemic illness~* Factors (such as exaggerated symptom report) that in the judgment of the principal investigator may make the outcome measures inaccurate~* Judged by investigator to be unlikely to complete study procedures

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Active MNS (Type: EXPERIMENTAL): Active, self-directed electrical stimulation of the right median nerve

Based on this trial design, predict the completion outcome and termination type (if applicable).